# Eszopiclone for Improving Sleep in Multiple Sclerosis (MS)

> **NCT00594087** · NA · COMPLETED · sponsor: **University of Vermont** · enrollment: 30 (actual)

## Conditions studied

- Relapsing Remitting Multiple Sclerosis
- Sleep Initiation and Maintenance Disorders
- Fatigue

## Interventions

- **DRUG:** eszopiclone
- **OTHER:** placebo

## Key facts

- **NCT ID:** NCT00594087
- **Lead sponsor:** University of Vermont
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-12
- **Primary completion:** 2008-05
- **Final completion:** 2008-06
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2009-01-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00594087

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00594087, "Eszopiclone for Improving Sleep in Multiple Sclerosis (MS)". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00594087. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*